Page last updated: 2024-09-03

duroquinol and Animal Mammary Carcinoma

duroquinol has been researched along with Animal Mammary Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Araya-Maturana, R; Ferreira, J; Jaña-Prado, F; Lapier, M; Martínez-Cifuentes, M; Maya, JD; Parra, E; Pavani, M; Pessoa-Mahana, H; Urra, FA	1

Other Studies

1 other study(ies) available for duroquinol and Animal Mammary Carcinoma

Article	Year
An ortho-carbonyl substituted hydroquinone derivative is an anticancer agent that acts by inhibiting mitochondrial bioenergetics and by inducing G₂/M-phase arrest in mammary adenocarcinoma TA3. Toxicology and applied pharmacology, 2013, Mar-15, Volume: 267, Issue:3 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Energy Metabolism; G2 Phase Cell Cycle Checkpoints; Hydroquinones; Male; Mammary Neoplasms, Animal; Mice; Mitochondria	2013

Article

Year

An ortho-carbonyl substituted hydroquinone derivative is an anticancer agent that acts by inhibiting mitochondrial bioenergetics and by inducing G₂/M-phase arrest in mammary adenocarcinoma TA3.

Toxicology and applied pharmacology, 2013, Mar-15, Volume: 267, Issue:3

Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Energy Metabolism; G2 Phase Cell Cycle Checkpoints; Hydroquinones; Male; Mammary Neoplasms, Animal; Mice; Mitochondria

2013